Pyoderma Gangrenosum - 17 Studies Found
Completed |
: Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease :
|
Completed |
: Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease : Crohn Disease : 2010-11-02 : Drug: Tacrolimus Once daily application for 12 weeks followed by 4 weeks observation. Optional 36 week o |
RECRUITING |
: Spesolimab in Pyoderma Gangrenosum : Pyoderma Gangrenosum : 2024-05-13 : 900 mg of spesolimab intravenously (IV) administered at Weeks 0, 3, 6, 9, 12 and 15. |
RECRUITING |
: Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG) : Pyoderma Gangrenosum : 2024-05-13 : Subjects with PG will be treated with 4 mg once daily of baricitinib for 24 weeks. |
NOT_YET_RECRUITING |
: Deucravacitinib in PG : Pyoderma Gangrenosum : 2024-05-13 : 6 mg tablet |
RECRUITING |
: Phase III Trial to Investigate Efficacy and Safety of Vilobelimab in Ulcerative Pyoderma Gangrenosum : Pyoderma Gangrenosum : 2024-05-13 : vilobelimab infusion |